Efficacy and safety of continuous infusion of factor VII concentrate in a factor VII-deficient patient at high risk for arterial thrombosis

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 6, 2004, Pages 519-520

  Mazoyer, Elisabeth ^a   Kevorkian, Jean Philippe ^a   Biyick, Elisabeth ^a   Bellucci, Sylvia ^a   Michalski, Catherine ^b   Drouet, Ludovic ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Laboratoire Francais du Fractionnement et des Biotechnologies   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTERY THROMBOSIS; BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ANGINA PECTORIS; BLOOD LOSS, SURGICAL; CORONARY STENOSIS; DIABETES MELLITUS, TYPE 2; DRUG EVALUATION; FACTOR VII; FACTOR VII DEFICIENCY; GOITER, NODULAR; HOMOZYGOTE; HUMANS; HYPERCHOLESTEROLEMIA; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PREMEDICATION; RISK FACTORS; SMOKING; THROMBOPHILIA; THYROIDECTOMY;

EID: 4444325648     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200408000-00013     Document Type: Letter

References (12)

1. Giansily-Blaizot M, Biron-Andreani C, Aguillar-Martinez P, de Moerloose P, Briquel ME, Goudemand J, et al. Inherited factor deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding. Br J Haematol 2002; 117:172-175.
2. Mariani G, Mannucci PM, Mazzucconi MG, Capitanio A. Treatment of congenital factor VII deficiency with a new concentrate. Thromb Haemost 1978; 39:675-682.
3. Schulman S, Jonhnsson H, Lindmarker P. Thrombotic complications after substitution with a FVII concentrate [Letter]. Thromb Haemost 1991; 66:619.
4. Escoffre M, Zini JM, Schliamser L, Mazoyer E, Soria C, Tobelem G. Severe arterial thrombosis in a congenitally factor VII deficient patient. Br J Haematol 1995; 91:739-741.
5. Mariani G, Hermann FH, Schulman S, Baratova A. Thrombosis in inherited factor VII deficiency. J Thromb Haemost 2003; 1:2153-2158.
6. Eikenboom JC, Bos CF, Briet E. Peri-operative replacement therapy with factor VII concentrate in a patient with severe factor VII deficiency. Thromb Haemost 1992; 67:285-286.
7. Ranchere JY, Menart C, Lienhart A, Attali O. Factor VII deficiency and surgery. Ann Fr Anesth Reanim 1999; 18:772-775 [in French].
8. Zimmermann R, Ehlers G, Ehlers W, von Voss H, Gobel U, Wahn U. Congenital factor VII deficiency. A report of four new cases. Blut 1979; 38:119-125.
9. Charpiat B, Laporte S, Mismetti P, Debize G, Ducerf C. Perioperative pharmacokinetics of factor VII concentrate during liver surgery in a patient with congenital factor VII deficiency: an individual mathematical model. Blood Coagul Fibrinolysis 2002; 13:457-460.
10. Eskandari N, Feldman N, Greenspoon JS. Factor VII deficiency in pregnancy treated with recombinant factor VIIa. Obstet Gynecol 2002; 99:935-937.
11. Horowitz MS, Rooks C, Horowitz B, Hiltgartner MW. Virus safety of solvent/detergent-treated antihaemophilic factor concentrate. Lancet 1988; 2:186-189.
12. Roberts PL, Dunkerley C. Effect of manufacturing process parameters on virus inactivation by solvent-detergent treatment in a high-purity factor IX concentrate. Vox Sang 2003; 84:170-175.